Does TOFACITINIB Cause Psoriasis? 1,390 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,390 reports of Psoriasis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.9% of all adverse event reports for TOFACITINIB.
1,390
Reports of Psoriasis with TOFACITINIB
0.9%
of all TOFACITINIB reports
295
Deaths
420
Hospitalizations
How Dangerous Is Psoriasis From TOFACITINIB?
Of the 1,390 reports, 295 (21.2%) resulted in death, 420 (30.2%) required hospitalization, and 243 (17.5%) were considered life-threatening.
Is Psoriasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 1,390 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Psoriasis?
SECUKINUMAB (21,976)
APREMILAST (19,255)
ADALIMUMAB (16,698)
ETANERCEPT (10,818)
RISANKIZUMAB-RZAA (6,896)
METHOTREXATE (6,283)
USTEKINUMAB (4,955)
INFLIXIMAB (3,524)
CERTOLIZUMAB PEGOL (3,428)
IXEKIZUMAB (2,818)
Which TOFACITINIB Alternatives Have Lower Psoriasis Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN